| Title |
Sexual Dysfunction associated with Second-Generation Antidepressants in Patients with Major Depressive Disorder: Results from a Systematic Review with Network Meta-Analysis
|
|---|---|
| Published in |
Drug Safety, December 2013
|
| DOI | 10.1007/s40264-013-0129-4 |
| Pubmed ID | |
| Authors |
Ursula Reichenpfader, Gerald Gartlehner, Laura C. Morgan, Amy Greenblatt, Barbara Nussbaumer, Richard A. Hansen, Megan Van Noord, Linda Lux, Bradley N. Gaynes |
| Abstract |
Sexual dysfunction (SD) is prevalent in patients with major depressive disorder (MDD) and is also associated with second-generation antidepressants (SGADs) that are commonly used to treat the condition. Evidence indicates under-reporting of SD in efficacy studies. SD associated with antidepressant treatment is a serious side effect that may lead to early termination of treatment and worsening of quality of life. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 124 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 19 | 15% |
| Student > Master | 15 | 12% |
| Other | 14 | 11% |
| Student > Ph. D. Student | 13 | 10% |
| Student > Postgraduate | 13 | 10% |
| Other | 28 | 23% |
| Unknown | 22 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 46 | 37% |
| Agricultural and Biological Sciences | 9 | 7% |
| Neuroscience | 9 | 7% |
| Psychology | 9 | 7% |
| Nursing and Health Professions | 6 | 5% |
| Other | 17 | 14% |
| Unknown | 28 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 April 2021.
All research outputs
#1,811,129
of 23,924,386 outputs
Outputs from Drug Safety
#182
of 1,736 outputs
Outputs of similar age
#21,188
of 314,199 outputs
Outputs of similar age from Drug Safety
#2
of 14 outputs
Altmetric has tracked 23,924,386 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,736 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 314,199 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.